Original articleCutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases
Key words
COVID-19
dermatology
Moderna
mRNA
Pfizer
public health
registry
SARS-CoV-2
vaccine
vaccine reaction
delayed hypersensitivity
delayed inflammatory reaction
zoster
shingles
delayed large local reaction
pityriasis rosea
local injection site reaction
erythromelalgia
urticaria
morbilliform
pernio
chilblains
vesicular
erythema multiforme
filler
vasculitis
Abbreviations used
IQR
interquartile range
mRNA
messenger RNA
Cited by (0)
Funding sources: COVID-19 registry support provided to Massachusetts General Hospital by the International League of Dermatological Societies for administration and maintenance and by the American Academy of Dermatology for in-kind administrative support.
IRB approval status: Exempt. The registry was reviewed by the Partners Healthcare (Massachusetts General Hospital) Institutional Review Board and was determined to not meet the definition of human subject research.
© 2021 by the American Academy of Dermatology, Inc.